When: Confirmed weekly close below $142.64 on expanding volume

Then: Exit remainder position

When: Relief rally to $146-$148 MA cluster

Then: Reduce 10-15%

HOLD with 8% position cap; collect 2.93% dividend; do not add at current levels; wait for pullback to 137-142 zone or confirmed close above 149.70 on volume above 12 million shares before increasing exposure

• Q4 FY26 EPS decline of 14.9% is not in the price given imminent Q1 FY27 earnings risk and accelerating Iran-driven input costs
• Premium SKUs representing approximately 25-30% of revenue are exposed to discretionary trade-down as consumer pyramid gets squeezed
• Gross margin compressed from 49.1 to 48.5 in a single quarter despite full pricing toolkit
• MACD cross at +0.31 is barely positive momentum emerging from downtrend; RSI of 54 is neutral, not bullish
• Upper Bollinger band tag at 149.58 followed by intraday high of 149.66 and close at 147.82 with declining volume of 8.66 million shares represents rejection, not test
• Volume spike of 13.3 million shares on October 6 was not confirmed on October 7 session
• Polymarket pricing zero Fed cuts in 2026 at 96% probability; base case ten year yield remains in 4.7-5.5% corridor at 43% probability
• PG's 2.93% dividend yield looks less attractive against 4.7-5.5% ten year; relative yield advantage from 2022-2024 defensive rotation has materially narrowed
• PG trading at 22.3x trailing earnings, 20x forward earnings, with PEG of 3.8; not mispriced but fully valued to rich
• 8% position cap is the single most important risk control proposal in the analysis
• Conservative HOLD means holding at 8% cap and demanding confirmation before incremental commitment, not holding full size and waiting to add

→ vs aggressive: Q4 FY26 earnings decline of 14.9% is not 'already in the price' because Q4 FY26 ended June 30 and Q1 FY27 reports in mid-October; market is now pricing the next quarter with imminent negative catalyst risk

→ vs aggressive: Premium SKUs at 25-30% of revenue are exposed to discretionary trade down in a consumer pyramid squeeze environment; moat-widener argument ignores trade-down behavior on Gillette Prestige and Olay ProX lines

→ vs aggressive: Technical indicators show rejection not breakout: MACD cross of +0.31 is barely positive, RSI of 54 is neutral, upper Bollinger tag at 149.58 with close at 147.82 on declining volume of 8.66 million is distribution not accumulation

→ vs aggressive: One-day volume spike of 13.3 million shares on October 6 followed by absent buyers on October 7 is not confirmation; it is the opposite

→ vs aggressive: Bond shock is not 'de-risked' but still present and structurally unfavorable; Polymarket pricing 96% probability of zero Fed cuts in 2026 confirms higher for longer regime

→ vs aggressive: PG at 22.3x trailing P/E and 3.8 PEG is not 'most mispriced' but fully valued to rich; margin compression story means growth rate denominator will shrink, making multiple look even more expensive

→ vs aggressive: Aggressive HOLD means full exposure at 147.82 with no cushion if breakout fails; conservative HOLD with 8% cap and dividend collection preserves capital and optionality

HOLD existing position at 5-8% cap with three conditional triggers: add up to 8% on Q1 beat with stable margins into 146-148 zone; hold without adding on margin-compressed quarter; maintain 8% ceiling and await confirmed breakout above 149.70 on >12M shares before any aggressive averaging down.

• HOLD is correct but requires a plan, not passive waiting
• Three specific triggers govern add/sell decisions rather than binary holds
• Technical confirmation above 149.70 on >12M shares required before adding
• Entry zone for incremental capital softened to 138-142 with basing pattern rather than 137
• Stop loss widened from 145.5 to 141.5-142 for new entries to accommodate range volatility
• 2.93% dividend is a real return, not passive waiting - income component understated by both other analysts
• PG's 0.377 beta is the core defensive thesis - 2022 drawdown was multiple compression not fundamentals
• Gross margin compressed 49.1 to 48.5 in single quarter showing pricing toolkit has limits
• 3.8 PEG requires execution perfection which got harder in most recent quarter
• Rate headwinds and defensive rotation flows roughly balanced, creating range-bound setup
• Q1 FY27 earnings print in approximately a week to ten days is the key near-term catalyst
• Iran-driven commodity inflation is accelerating, not reversing - Q1 confirmation risk is real

→ vs aggressive: Q4 FY26 decline already priced but Q1 FY27 print in ~10 days could confirm deterioration; 149.66 fade on declining volume is indecision not accumulation; 3.8 PEG requires execution perfection, not a mispricing

→ vs conservative: Beta of 0.377 structurally prohibits catastrophic downside; 2022 drawdown was multiple event not fundamentals; dividend was never threatened; framing existing holders as avoiding loss misses 2.93% income component; 137 entry catches a falling knife, softened to 138-142 with basing confirmation